|
Video Viewpoint Strategy Session: Optimizing Treatment and Functional Outcomes in Head and Neck Squamous Cell Carcinoma
Gain expert insight on emerging treatment approaches for patients with head and neck squamous cell carcinoma, incuding the safety and tolerabilty of emerging treatments, survivorship care, and much more. This activity is presented by leading experts, Barbara Burtness, MD, Professor of Medicine at Yale School of Medicine and Smilow Cancer Hospital, and Lynsey Teulings, NP, Nurse Practitioner at Yale School of Medicine and Smilow Cancer Hospital. Start the activity now.
STATEMENT OF NEED
H... |
|
|
Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies
Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, as well as discuss emerging therapies and monitoring strategies for patient care. Start the activity ... |
|
Medical Moments Webcast Series: Promising Options for HER2+ Gastric Cancer Treatment: Focus on Emerging ADCs
This three-part webcast series is targeted to medical oncologists, molecular pathologists, and other clinicians who are involved in diagnosis and treatment of HER2+ gastric cancer. Moderated expertly by the series Chair, Dr. David Ilson from Memorial Sloan Kettering, our knowledgeable faculty will examine the latest testing guidelines and clinical trial data, exploring the burgeoning evidentiary base in support of an expanded role for antibody-drug conjugates in oncology, and specifically in H... |
|
Applying ADAURA in Practice: Implications For Early Stage EGFRM NSCLC
This educational initiative is targeted to medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists and molecular pathologists who are involved in diagnosis of early stage NSCLC that is surgically resectable with curative intent. In addition to examining the latest ADAURA trial data and the potential utility of adjuvant osimertinib in stage IB-IIIA EGFRm NSCLC, the practice-changing implications of these results will also be explored from a variety of perspectives with thr... |
|
|
Podcast: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer
In this episode of Oncology Data Advisor TM, learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Listen now!
STATEMENT OF NEED
Th... |
|
|
Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer
Learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Start the activity now!
STATEMENT OF NEED
There are an estimated 13,800 new c... |
|
|
Addressing Challenges in Diagnosis and Treatment of Low-Grade Upper Tract Urothelial Carcinoma
OVERVIEW
Upper tract urothelial carcinoma (UTUC) has many similarities to bladder carcinoma, but also some important differences. Join Dr. Seth Lerner, as he contrasts these 2 diseases, as well as important differences between low-grade and high-grade UTUC. Dr. Lerner highlights important considerations in the instruments, imaging, and biopsy techniques for diagnosing low-grade UTUC. Surgical options are considered, with a focus on patient selection for endoscopic nephron-sparing surgery. The... |
|
Clinical Diversity and Genetic Variation in Lysosomal Disorders
Explain the principles of Pathogenic Processes in LSDs.
Explain that lysosomal composition, shape, contents, numbers differ between cell types
and have an effect on disease expression.
Review the evolving understanding of lysosomal autophagy functions. |
|
|
Video ViewPoint Strategy Session: Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers
Gain expert insight and strategies for the management of anaplastic thyroid cancer including emerging data on immunotherapies, and treatment to manage adverse events. This activity is presented by leading experts, Jochen Lorch, MD, MSc, Director Thyroid Cancer Center, Dana-Farber Cancer Institute, and Carolyn Grande, CRNP, AOCNP®, Oncology Nurse Practitioner, Abramson Cancer Center.
STATEMENT OF NEED
Thyroid cancer is one of the most prevalent cancers in the United States. An estimated ... |
|
|
Metastatic Triple-Negative Breast Cancer: Applying Treatment Advances to Personalized Care
Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA, and a prominent authority on TNBC, provides perspectives on personalized care plans for patients with metastatic TNBC, efficacy and safety of emerging treatments, strategies to improve quality of life for patients with metastatic TNBC, and much more! Start the activity now!
STATEMENT OF NEED
With an estimated 284,200 new cases per year, breast cancer is the mo... |
|
|
Podcast: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma
Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now!
STATEMENT ... |
|
|
Video Viewpoint Strategy Session: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma
Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now!
STATEMENT ... |
|
|
Acromegaly Highlights from ENDO 2021
This CME activity highlights the latest research about Acromegaly that was presented at ENDO 2021, the annual meeting of the Endocrine Society. This activity provides expert analysis on that research and its clinical relevance for busy members of the care team in order to help them care for patients with acromegaly. |
|
|
Video Viewpoint Strategy Session: Advances in the Treatment of Relapsed/Refractory Immune Thrombocytopenia
Learn new advances in the treatment of relapsed or refractory immune thrombocytopenia, including treatment differentiation, efficacy and safety strategies, and much more. This activity features perspectives from two noted experts in the field, Dr. Keith McCrae, Director of Benign Hematology at the Cleveland Clinic Taussig Cancer Center; and Ms. Phyllis McKiernan, Advanced Practice Nurse in Blood & Marrow Stem Cell Transplantation at the John Theurer Cancer Center, Hackensack Meridian Health.
... |
|
|
Enhancing the Clinical Outcomes of Patients with Extensive–Stage Small Cell Lung Cancer
Anne Chiang, MD, PhD, Yale School of Medicine, a leading expert on small cell lung cancer, for an in-depth presentation on patient outcomes in extensive-small cell lung cancer. Dr. Chiang will present evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more! Start the activity now!
An estimated 228,820 new cases of lung cancer are reported in the United... |
|
|
New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertion–NSCLC
Discover new developments in the diagnosis and treatment of EGFR exon-20 Insertion–Mutant NSCLC and assess emerging efficacy and safety data on novel targeted therapies. This activity features expert insights from Helena Yu, MD, Memorial Sloan Kettering Cancer Center, and Maria Arcila, MD, Memorial Sloan Kettering Cancer Center.
This activity is also available as a podcast.
An estimated 235,760 new cases of lung cancer are reported in the United States annually, and 131,880 people die... |
|
|
Current and Emerging Therapies for Lysosomal Storage Disease
This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available for other attendees. |
|
|
An Interactive Guide to the Underdiagnosed, Underestimated, but Treatable Metabolic Disorders
This infographic activity uses a self-directed, visual update to the state-of-the-art diagnosis and management of treatable lysosomal storage disorders. Much of what you learned in your primary training may be outdated because of rapid advances in genetic, molecular, and clinical approaches to these conditions. While the LSDs were often fatal conditions, new treatments have completely changed the possible outcomes for patients, but a major barrier is recognition of the condition in time for tr... |
|
|
New Opportunities in Advanced KRAS Mutation-Positive NSCLC
In this CME/NCPD activity, D. Ross Camidge, MD, PhD, of the University of Colorado, and Beth Sandy, MSN, CRNP, OCN®, of the University of Pennsylvania, discuss novel treatments for advanced KRAS mutation-positive NSCLC and how to manage adverse events associated with small molecule inhibitors. Start now!
An estimated 228,820 new cases of lung cancer are reported in the United States annually, and 135,720 people die of the disease (ACS, 2020). Approximately 84% of cases are classified as... |
|
|
Fabry Disease Research Highlights
At WORLDSymposium 2021, new information and data were presented on Fabry disease, a rare lysosomal storage disorder. This CME activity highlights the latest information about Fabry disease from WORLDSymposium 2021 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition. |
|
|
Gaucher Disease Research Highlights: ASH 2020
At the American Society of Hematology Annual Meeting (ASH 2020), new information and data were presented on Gaucher disease, a rare lysosomal storage disorder, that requires a team of health care professionals to properly manage. This CME activity highlights the latest information about Gaucher disease from ASH 2020 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition.
Activity Faculty
|
|
|
Meeting the Challenges in Management of Sickle Cell Disease
No longer a life-threatening disease, sickle cell disease (SCD) has become a chronic disease with life-threatening events that requires coordinated care by a multidisciplinary care team. Join Michael R. DeBaun, MD, MPH, and Collin Montgomery, APRN, as they discuss the acute and chronic complications experienced by individuals with SCD and the barriers they often encounter. The faculty offer real-world strategies for overcoming these barriers to improve the quality of life and other health outc... |
|
|
Update on Therapeutic Advances in T-Cell Lymphoma
Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity!
STATEMENT OF NEED
Each year, 74,240 new cases of non-Hodgkin lymphoma are diagnosed and 19,940 people die of the disease (ACS, 2020). Among these cases, 12% to 15% are classified as peripheral T-cell l... |
|
|
Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in Adult Patients
STATEMENT OF NEED
Atopic dermatitis is a severe form of eczema pathologically characterized by skin barrier disruption mediated by a type 2 helper T-cell immune response. The incidence of atopic dermatitis is high, estimated to be approximately 15% to 20% in children and 1% to 3% in adults worldwide (Avena-Woods, 2017). In addition to the hallmark clinical symptoms of eczema and intense pruritus, atopic dermatitis is associated with a substantial and multifaceted patient-reported burden tha... |
|
Expert Updates in COVID19: An Animated Video Series
Five animated videos clearly explain managing patients with COVID19, lung disease, ARDS, or long-COVID. Hear from the leading pulmonologists on best practices based on the latest literature. |
|
|
Assessing a Patient With Long COVID-19: An Interactive Case Scenario
In this interactive case, the physician recommends a series of assessments for your patient with Long-COVID symptoms. For each assessment, the user chooses the outcome to hear recommendations from the experts. |
|
|
TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic
In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment.
Topics covered in this webcast series include:
COVID-19–Related Complications in Persons Living With HIV (PLWH);
COVID-19 Testing Strategies;
Home Care for PLWH Diagnosed With COVID-1... |
|
|
Eye on Neuromyelitis Optica Spectrum Disorder (NMOSD)
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease often characterized by sporadic and repeated inflammatory flare ups that can impact the optic nerve and/or spinal cord. With each repeated attack, additional permanent neurological damage will accrue. This CME activity highlights the important role both ophthalmologists and neurologists play in diagnosing and treating NMOSD most efficiently. |
|
|
Pulmonary Arterial Hypertension (PAH) Highlights from CHEST 2020
Although CHEST 2020 was not a live, in-person meeting, new information and data regarding pulmonary arterial hypertension (PAH) will still be published but will not be easily accessible to the care team involved in the diagnosis and management of patients with this rare disease who need to know and incorporate the latest information into patient care. This CME activity highlights the latest research on PAH to help clinicians keep up to date on the most efficient ways to manage their patients. |
|
|
Understanding Evolving Therapeutic Strategies for Graft-Versus-Host Disease (Module 1: Diagnosis, Risk Assessment, and Staging; Module 2: Current and Emerging Therapeutic Strategies)
STATEMENT OF NEED
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents during the first year following HSCT but may develop in subsequent years and most commonly affects the ... |
|
|
Optimal Prehospital Management of Seizure Emergencies
In this program, the faculty will review and provide updates on the guidelines for managing seizure emergencies and address how participants can reduce the barriers to prehospital treatment through the use of Seizure Action Plans. They also will discuss recent clinical trials that may improve caregiver acceptance of rescue medications for status epilepticus. In addition, the faculty will address the similarities and differences in managing seizure emergencies for pediatric and adult patients. |
|
|
Research Updates in Gout: Improving Response Rate to Therapy
Dr. Brian Mandell and Dr. Naomi Schlesinger discuss recent published evidence related to gout, as well as study results presented at the American College of Rheumatology Convergence 2020 virtual annual meeting. Dr. Schlesinger begins with an introduction on a recent published systematic review indicating that the manifestations of gout extend beyond the joints, affecting other organs and tissues. Dr. Schlesinger also provides an overview of some of the challenges encountered in clinical practi... |
|
|
A Case-Based Roadmap for Improved Patient Outcomes in Psoriatic Arthritis
Patients with psoriatic arthritis (PsA) experience significant disease burden due to incomplete diagnostic evaluation and suboptimal use of effective therapies. In this case-based activity, Dr. Leonard Calabrese of the Cleveland Clinic addressing these practice gaps by sharing his recommendations for patient management at critical decision points in the diagnosis and treatment of patients with PsA. Dr. Calabrese also discusses the important role of shared decision-making over the course of the... |
|
|
Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma
STATEMENT OF NEED
Merkel cell carcinoma is a rare and aggressive neuroendocrine tumor of unknown origin that typically presents in older white and immunocompromised adults. An estimated 2,488 cases are diagnosed in the United States annually (Paulson et al, 2018). The incidence of MCC has risen rapidly during the past few decades, which has been attributed in part to people living longer with increased sun exposure and weakened immune systems, a feature that suggests an infectious origin an... |
|
|
New Data and Clinical Perspectives on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type affecting men in the United States. An estimated 191,930 new cases are diagnosed annually, and 33,330 people die from the disease (ACS, 2020). Most patients with metastatic hormone-sensitive prostate cancer (HSPC) present with relapse after local treatment, while approximately 5% of all prostate cancer patients present with de novo metastatic HSPC (Ng et al, 2020). The five-year overall survival rate for metastatic HSPC remains... |
|
|
Expert Guidance on New Advances in Renal Cell Carcinoma
STATEMENT OF NEED
Kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States (ACS, 2020). An estimated 73,750 new cases are reported annually and 14,830 people die of the disease. Renal cell carcinoma, which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. Due to its often asymptomatic presentation, many patients have advanced disease at ... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer
STATEMENT OF NEED
Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population (ACS, 2020). Although many women benefit from regular screening as well as earlier and improved treatment, approximately 6% present with metastatic disease, and up to 30% with no initial lymph node involvement eventually develop metastatic disease (Siegel et al, 2020; Mortensen et al, 2018). Women with metastat... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma
STATEMENT OF NEED
Of the estimated 74,200 new cases of non-Hodgkin lymphoma each year in the United States, approximately 22% are FL, an indolent, difficult-to-treat B-cell malignancy (ACS, 2019; NCCN, 2019). Most patients are diagnosed at an average age of 63 years (NCI, 2019). Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrence... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Advanced Soft Tissue Sarcoma
STATEMENT OF NEED
Soft tissue sarcomas are a heterogeneous group of malignancies that arise primarily from the mesodermal tissues of the extremities, trunk and retroperitoneum, and head and neck. An estimated 13,130 new cases are diagnosed in the United States annually and 5,350 people die of the disease. Surgical resection is the mainstay of treatment for localized soft tissue sarcoma, with radiation and chemotherapy commonly used as adjuncts. However, nearly 50% of patients will experienc... |
|
|
Food Allergy: From Primary Prevention to Treatment and Intervention Online
This online offering includes 19 videos of lectures and panel discussions on the diagnosis and management, specific syndromes, treatment, and research and prevention of food allergy. The videos were recorded at a live course that took place at a live AAAAI course held in early September, 2019.
The intent of the videos is to allow learners to increase their knowledge related to the diagnosis and management of food allergic patients. It highlights the latest evidence related to food allergie... |
|
|
Identifying and Evaluating Child Abuse
This course teaches how to perform evaluations in cases of suspected child abuse, document injuries appropriately, and work with law enforcement and community agencies.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Perform appropriate medical evaluations of suspected abuse cases.
- Obtain an appropriate history in suspected child abuse cases.
- Communicate effectively with investigative services.
- Document abuse accurately i... |
|
|
Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer
Join the discussion! We bring the expert to you. LIVE. VIRTUAL. FLEXIBLE. Interactive discussion on optimization of RET+ testing in NSCLC and thyroid cancer, and the pathways for enhancing collaboration between pathologists and oncologists to improve patient care. Choose a date that works best with your schedule!
Your questions answered on precision medicine!
- What are the roles of biomarkers?
- When should biomarker testing occur?
- What do the test results mean?
- How does the muta... |
|
|
Current Management of Domestic Violence - Responding to IPV
This course helps you screen for, respond to, document, and manage your patients who are suffering from abusive relationships. Includes up to 17 patient cases in 5 different specialties.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Screen patients for intimate partner violence (IPV) and appropriately respond to disclosures of abuse.
- Recognize patterns of abuse and properly document IPV.
- Assess the safety of IPV victims.
... |
|
|
Culture & End of Life Care: Patients' Beliefs and Values
This course helps you elicit and respond to patients' faith-based values, and facilitate communication with others who will be involved in patients' end-of-life care.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Ask questions that will help you gather information on the patient's Explanatory Model, or understanding, of her illness experience.
- Organize your approach to culture using the LEARN mnemonic: Listen, Explain, Acknow... |
|
|
Culture & End of Life Care: Conversations with Patients and Families
This course helps you sort the facts surrounding an ethical question in an end-of-life situation, develop options for resolving ethical issues, and negotiate treatment plans with patients who elect to use CAM along with conventional care.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Compare methods of giving bad news to a patient.
- Consider ways to respond when a patient is overwhelmed and raises questions that are difficult ... |
|
|
Culture & End of Life Care: Collaborating with Interdisciplinary Partners
This course helps you identify possible pitfalls in handling interdisciplinary conflict, assess strategies for addressing interdisciplinary conflicts effectively, and identify strategies for successful communication when working with an interpreter.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Analyze advantages for using a skilled interpreter with limited English proficiency (LEP) patients or patients who don't speak English a... |
|
|
Counseling Patients About Obesity
This course helps you incorporate knowledge of prevalence of obesity, mitigate weight bias in clinical settings, utilize four motivational interviewing techniques in a clinical scenario, and identify the steps of the 5 A's Behavior Change model for lifestyle counseling in a clinical scenario.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Incorporate into practice knowledge of prevalence of obesity in the U.S.
- List two strateg... |
|
|
An Overview of Medical Ethics
This course covers the principles of ethical and moral conduct, ethical relationships, physician responsibility, privacy, consent and confidentiality, and ethical practice of controversial medical topics and procedures.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Identify the principles of ethical or moral conduct for physicians
- Explain the basis for ethical relationships between physicians and patients
- Understand the ne... |
|
|
Accident or Injury? Managing Abuse in Younger Children
This course teaches how to recognize and evaluate cases of suspected child physical abuse and child sexual abuse in young children.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Perform appropriate medical evaluations for suspected abuse, including:
- Obtaining an accurate history.
- Performing a comprehensive physical exam.
- Differentiating between accidental and non-accidental injury.
- Documenting your assessment accurat... |
|
|
A Guide to the Secrets of Never-Sued Physicians
This course teaches techniques that enable you to avoid the most unpleasant aspect of medical practice: a malpractice suit.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Describe the differences between people who become patients and those who choose not to seek medical care.
- Identify the events that turn patients into plaintiffs.
- Refrain from using specific physician behaviors that precipitate lawsuits.
- List the behav... |
|